Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Revilla

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Circulation. Cardiovascular Interventions|November 28, 2013
Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantationRutger-Jan Nuis, Jan-Malte Sinning, Josep Rodés-Cabau, et al.
JACC. Cardiovascular Interventions|December 9, 2023
Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up OutcomesSara Blasco-Turrión, Kasparas Briedis, Rodrigo Estévez-Loureiro, et al.
JACC. Cardiovascular Interventions|August 6, 2016
Mitral Regurgitation After Transcatheter Aortic Valve Replacement: Prognosis, Imaging Predictors, and Potential ManagementCarlos Cortés, Ignacio J Amat-Santos, Luis Nombela-Franco, et al.
International Journal of Cardiology|January 3, 2022
Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbancesSandra Santos-Martinez, Jonathan Halim, Alex Castro-Mejía, et al.
Cardiology Journal|April 12, 2021
Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19Gonzalo Cabezón Villalba, Ignacio J Amat-Santos, Carlos Dueñas, et al.
BMJ Open|February 15, 2018
Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre studyIgnacio J Amat-Santos, Pablo Catalá, Felipe Diez Del Hoyo, et al.
BMJ Open|August 7, 2017
Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trialPaloma Gastelurrutia, Carolina Gálvez-Montón, Maria Luisa Cámara, et al.
Medicina Clinica|June 5, 2021
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysisÁlvaro Aparisi, Pablo Catalá, Ignacio J Amat-Santos, et al.
Journal of the American Heart Association|September 18, 2024
Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical TrialIgnacio J Amat-Santos, Diego López-Otero, Luis Nombela-Franco, et al.
Medicina Clinica (English Ed.)|May 9, 2022
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysisÁlvaro Aparisi, Pablo Catalá, Ignacio J Amat-Santos, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Circulation. Cardiovascular Interventions|November 28, 2013
Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantationRutger-Jan Nuis, Jan-Malte Sinning, Josep Rodés-Cabau, et al.
JACC. Cardiovascular Interventions|December 9, 2023
Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up OutcomesSara Blasco-Turrión, Kasparas Briedis, Rodrigo Estévez-Loureiro, et al.
JACC. Cardiovascular Interventions|August 6, 2016
Mitral Regurgitation After Transcatheter Aortic Valve Replacement: Prognosis, Imaging Predictors, and Potential ManagementCarlos Cortés, Ignacio J Amat-Santos, Luis Nombela-Franco, et al.
International Journal of Cardiology|January 3, 2022
Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbancesSandra Santos-Martinez, Jonathan Halim, Alex Castro-Mejía, et al.
Cardiology Journal|April 12, 2021
Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19Gonzalo Cabezón Villalba, Ignacio J Amat-Santos, Carlos Dueñas, et al.
BMJ Open|February 15, 2018
Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre studyIgnacio J Amat-Santos, Pablo Catalá, Felipe Diez Del Hoyo, et al.
BMJ Open|August 7, 2017
Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trialPaloma Gastelurrutia, Carolina Gálvez-Montón, Maria Luisa Cámara, et al.
Medicina Clinica|June 5, 2021
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysisÁlvaro Aparisi, Pablo Catalá, Ignacio J Amat-Santos, et al.
Journal of the American Heart Association|September 18, 2024
Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical TrialIgnacio J Amat-Santos, Diego López-Otero, Luis Nombela-Franco, et al.
Medicina Clinica (English Ed.)|May 9, 2022
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysisÁlvaro Aparisi, Pablo Catalá, Ignacio J Amat-Santos, et al.
Pageof 10